State-of-the-art of intrauterine contraception

References

• Van Kets H, Wildemeersch D, van der Pas H, et al. IUD expulsion solved with implant technology. Contraception 1995; 51: 87–92
   PubMed Web of Science ®Google Scholar
• Van Kets H, van der Pas H, Thiery M, et al. The GyneFix implant systems for interval, postabortal and postpartum contraception: a significant advance in long-term reversible contraception. International Study Group on Intrauterine Drug Delivery. Eur J Contracept Reprod Health Care 1997; 2: 1–13
   PubMedGoogle Scholar
• Wildemeersch D, Batár I, Affandi B, et al. The ‘frameless’ intrauterine system for long-term, reversible contraception: A review of 15 years of clinical experience. J Obstet Gynaecol Res 2003; 29: 164–173
   PubMed Web of Science ®Google Scholar
• Wu S, Hu J, Wildemeersch D. Performance of the frameless GyneFix and the TCu380A IUDs in a 3-year multicenter, randomized, comparative trial in parous women. Contraception 2000; 61: 91–98
   PubMed Web of Science ®Google Scholar
• Cao X, Zhang W, Gao G, et al. Randomized comparative trial in parous women of the frameless GyneFix and the TCu380A intrauterine devices: long-term experience in a Chinese family planning clinic. Eur J Contracept Reprod Health Care 2000; 5: 135–140
   PubMedGoogle Scholar
• Geyoushi B E, Randall S, Stones R W. GyneFix: UK experience. Eur J Contracept Reproduct Health Care 2002; 7: 7–14
   PubMed Web of Science ®Google Scholar
• Dennis J, Webb A, Kishen M. Expulsions following 1000 GyneFix insertions. J Fam Plann Reproduct Health Care 2001; 27: 135–138
   PubMed Web of Science ®Google Scholar
• Hui-Qin L, Zhuan-Chong F, Yu-Bao W, et al. Performance of the frameless IUD (Flexigard prototype inserter) and the TCu380A after six years as part of a WHO multicenter randomized comparative clinical trial in parous women. Adv Contracept 1999; 15: 201–209
   PubMedGoogle Scholar
• Batar I, Wildemeersch D. The reliability of the anchoring concept for suspension of bioactive substances in the human uterus evaluated by measuring the removal force: results after long-term use. Contraception 2004; 69: 501–503
   PubMed Web of Science ®Google Scholar
• Delbarge W, Batar I, Bafort M, et al. Return to fertility in nulliparous and parous women after removal of the GyneFix intrauterine contraceptive system. Eur J Contracept Reproduct Health Care 2002; 7: 24–30
   PubMed Web of Science ®Google Scholar
• Wildemeersch D, Van Kets H, Vrijens M, et al. Intrauterine contraception in adolescent women. The GyneFix intrauterine implant. Ann NY Acad Sci 1997; 816: 440–450
   PubMed Web of Science ®Google Scholar
• Cao X, Zhang W, Zhao X, et al. Three-year efficacy and acceptability of the GyneFix 200 intrauterine system. Contraception 2004; 69: 207–211
   PubMed Web of Science ®Google Scholar
• Wildemeersch D, Rowe P J. Assessment of menstrual blood loss in Belgian users of the frameless copper-releasing IUD with copper surface area of 200 mm2 and users of a copper-levonorgestrel-releasing intrauterine system. Contraception 2004; 70: 169–172
   PubMed Web of Science ®Google Scholar
• Reid P C, Virtanen-Kari S. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. BJOG 2005; 112: 1121–1125
   PubMed Web of Science ®Google Scholar
• Hurskainen R, Paavonen J. Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding. Curr Opin Obstet Gynecol 2004; 16: 487–490
   PubMed Web of Science ®Google Scholar
• Kingman C E, Kadir R A, Lee C A, et al. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders. BJOG 2004; 111: 1425–1428
   PubMed Web of Science ®Google Scholar
• Rauramo I, Elo I, Istre O. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Obstet Gynecol 2004; 104: 1314–1321
   PubMed Web of Science ®Google Scholar
• Hurskainen R, Teperi J, Aalto A M, et al. Levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of essential menorrhagia: predictors of outcome. Acta Obstet Gynecol Scand 2004; 83: 401–403
   PubMed Web of Science ®Google Scholar
• Lockhat F B, Emembolu J E, Konje J C. Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel. Fertil Steril 2005; 83: 398–404
   PubMed Web of Science ®Google Scholar
• Fedele L, Berlanda N. Emerging drugs for endometriosis. Expert Opin Emerg Drugs 2004; 9: 167–177
   PubMedGoogle Scholar
• Hampton N R, Rees M C, Lowe D G, et al. Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women. Hum Reprod 2005; 20: 2653–2660
   PubMed Web of Science ®Google Scholar
• Ratsula K. Clinical performance of a levonorgestrel- releasing intracervical contraceptive device during the first two years of use. Contraception 1989; 39: 187–193
   PubMed Web of Science ®Google Scholar
• Pakarinen P, Luukkainen T. Five years' experience with a small intracervical/intrauterine levonorgestrel- releasing device. Contraception 2005; 72: 342–345
   PubMed Web of Science ®Google Scholar
• Sturdee D W, Rantala M L, Colau J C, et al. The acceptability of a small intrauterine progestogen- releasing system for continuous combined hormone therapy in early postmenopausal women. Climacteric 2004; 7: 404–411
   PubMed Web of Science ®Google Scholar
• Wildemeersch D, Schacht E, Wildemeersch P. Performance and acceptability of intrauterine release of levonorgestrel with a miniature delivery system for hormonal substitution therapy, contraception and treatment in peri and postmenopausal women. Maturitas 2003; 44: 237–245
   PubMed Web of Science ®Google Scholar
• Wildemeersch D, Janssens D, Vrijens M, et al. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems. Contraception 2005; 71: 465–469
   PubMed Web of Science ®Google Scholar
• Andersson K. The levonorgestrel intrauterine system: more than a contraceptive. Eur J Contracept Reprod Health Care 2001; Suppl(1)15–22
   Google Scholar
• Backman T, Rauramo I, Huhtala S, et al. Pregnancy during the use of levonorgestrel intrauterine system. Am J Obstet Gynecol 2004; 190: 50–54
   PubMed Web of Science ®Google Scholar
• Batár I. SilverLily and GoldLily – a novel family of intrauterine contraception (in Latvian). Dzemdnieciba un Ginecologija (Latvian J Obstet Gynecol) 2001; 3: 26–29
   Google Scholar